List of insiders holdings for CORCEPT THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Tammenoms Bakker Juliet 10% Owner | 2016-12-19 13:29:28 | 133,539 10,956,002 | 11,089,541 | Form 4 |
| ANDERSON DAVID L Former 10% Owner | 2013-02-13 20:10:23 | 0 6,420,729 | 6,420,729 | Form 5 |
| YOUNGER WILLIAM H JR Former 10% Owner | 2013-02-13 20:24:40 | 0 6,333,795 | 6,333,795 | Form 5 |
| COXE TENCH Former 10% Owner | 2013-02-13 19:47:54 | 0 6,317,984 | 6,317,984 | Form 5 |
| GAITHER JAMES C Former 10% Owner | 2013-02-13 19:27:32 | 37,002 5,508,259 | 5,545,261 | Form 5 |
| SUTTER HILL VENTURES BAKER G LEONARD JR ANDERSON DAVID L YOUNGER WILLIAM H JR COXE TENCH GAITHER JAMES C SWEET DAVID E SHEEHAN ANDREW T Speiser Michael L BIRD JEFFREY W 10% Owner | 2016-02-16 14:22:06 | 4,505,527 0 | 4,505,527 | Form 13G |
| SUTTER HILL VENTURES WHITE JAMES N 10% Owner | 2016-02-16 14:22:06 | 4,505,527 0 | 4,505,527 | Form 13G |
| BELANOFF JOSEPH K Chief Executive Officer | 2024-08-02 16:42:32 | 539,228 2,483,107 | 3,022,335 | Form 4 |
| SCHATZBERG ALAN F Director 10% Owner | 2008-01-31 11:31:16 | 2,738,749 0 | 2,738,749 | Form 13G |
| ALTA BIOPHARMA PARTNERS II LP ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC ALTA EMBARCADERO PARTNERS II LLC DELEAGE JEAN CHAMPSI FARAH ALTA PARTNERS II INC 10% Owner | 2011-02-03 15:34:10 | 2,641,076 0 | 2,641,076 | Form 13G |
| ALTA BIOPHARMA PARTNERS II LP MARDUEL ALIX DELEAGE JEAN CHAMPSI FARAH ALTA BIOPHARMA MANAGEMENT II LLC ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC ALTA PARTNERS II INC 10% Owner | 2011-02-03 15:34:10 | 2,641,076 0 | 2,641,076 | Form 13G |
| ALTA BIOPHARMA PARTNERS II LP ALTA BIOPHARMA MANAGEMENT II LLC ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC ALTA PARTNERS II INC DELEAGE JEAN CHAMPSI FARAH 10% Owner | 2011-02-03 15:34:10 | 2,641,076 0 | 2,641,076 | Form 13G |
| Longitude Venture Partners L.P. Longitude Capital Partners LLC Tammenoms Bakker Juliet Longitude Capital Associates L.P. 10% Owner | 2017-06-13 16:15:39 | 2,344,998 0 | 2,344,998 | Form 13D |
| BERNAL RONALD D 10% Owner | 2005-02-01 20:02:48 | 0 2,298,834 | 2,298,834 | Form 3 |
| WILSON JAMES N Director | 2024-05-28 19:53:39 | 0 2,215,093 | 2,215,093 | Form 4 |
| Loewy Caroline M Chief Financial Officer | 2008-12-02 11:57:33 | 800,000 0 | 800,000 | Form 4 |
| SINGER DAVID B Director | 2008-02-13 16:47:15 | 726,669 66,998 | 793,667 | Form 5 |
| Lo Steven SVP Oncology | 2015-11-16 18:21:06 | 585,416 0 | 585,416 | Form 4 |
| Guyer William Chief Development Officer | 2024-10-03 16:27:05 | 465,796 0 | 465,796 | Form 4 |
| ENRIGHT PATRICK G Director | 2017-03-20 16:36:22 | 272,281 114,675 | 386,956 | Form 4 |
| FISHMAN ROBERT S Chief Medical Officer | 2018-11-09 17:06:30 | 329,000 0 | 329,000 | Form 4 |
| Dyckerhoff Stefan A 10% Owner | 2013-07-10 20:12:04 | 0 280,365 | 280,365 | Form 3/A |
| Pullara Samuel J III 10% Owner | 2013-07-10 20:15:08 | 0 280,365 | 280,365 | Form 3/A |
| SANDS GREGORY P 10% Owner | 2011-10-25 18:01:31 | 23,889 246,043 | 269,932 | Form 4 |
| PENHOET EDWARD 10% Owner | 2010-04-06 20:12:15 | 41,250 180,204 | 221,454 | Form 4 |
| Harper James A Director | 2010-07-12 17:03:38 | 209,900 7,500 | 217,400 | Form 4 |
| Paperboy Ventures LLC Director | 2009-05-11 17:42:40 | 209,694 0 | 209,694 | Form 4 |
| ROE ROBERT L President and Secretary | 2013-02-01 19:26:03 | 200,000 0 | 200,000 | Form 4 |
| Grauer Andreas Chief Medical Officer | 2021-02-08 17:15:30 | 200,000 0 | 200,000 | Form 4 |
| BRADBURY DANIEL Director | 2019-02-12 21:44:18 | 0 130,575 | 130,575 | Form 4 |
| LeDoux Anne M VP & Controller | 2015-09-29 18:30:30 | 125,000 0 | 125,000 | Form 4 |
| Hunt Hazel Chief Scientific Officer | 2024-08-05 18:31:52 | 118,581 0 | 118,581 | Form 4 |
| Maduck Sean See Remarks | 2024-09-05 20:08:37 | 85,083 20,000 | 105,083 | Form 4 |
| ANDERSSON ALLEN Director | 2009-06-29 14:02:01 | 0 97,143 | 97,143 | Form 4/A |
| TURNER JOSEPH L Director | 2015-06-23 15:03:19 | 50,000 0 | 50,000 | Form 4/A |
| Robb Gary Charles Chief Business Officer | 2024-10-01 19:55:33 | 36,809 9,665 | 46,474 | Form 4 |
| Cannon Gillian Director | 2024-05-21 18:25:15 | 30,000 0 | 30,000 | Form 4 |
| Park Kimberly Director | 2024-05-21 18:47:35 | 30,000 0 | 30,000 | Form 4 |
| Murray Joshua M. Director | 2024-05-21 18:42:49 | 30,000 0 | 30,000 | Form 4 |
| Alton Gregg H Director | 2024-05-21 18:30:14 | 30,000 0 | 30,000 | Form 4 |
| MAHONEY DAVID L Director | 2024-05-21 18:28:53 | 30,000 0 | 30,000 | Form 4 |
| BAKER G LEONARD JR Director | 2024-05-21 18:25:19 | 30,000 0 | 30,000 | Form 4 |
| COOK JOSEPH C JR Director | 2015-06-22 21:53:28 | 30,000 0 | 30,000 | Form 4 |
| KURLAND FRED Chief Financial Officer | 2006-03-06 18:22:12 | 25,000 0 | 25,000 | Form 4 |
| GALA RENEE D Director | 2018-08-22 17:38:48 | 25,000 0 | 25,000 | Form 4 |
| Mokari Atabak Chief Financial Officer | 2024-09-05 20:24:14 | 12,518 0 | 12,518 | Form 4 |
| Lyon Joseph Douglas See Remarks | 2024-09-05 20:27:19 | 9,905 0 | 9,905 | Form 4 |
| Swisher Daniel N JR Director | 2024-08-05 19:10:24 | 0 0 | 0 | Form 4 |
| KAPP STEVEN Director | 2004-04-14 16:04:07 | 0 0 | 0 | Form 3 |